Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Share-based Compensation: 2019-2024

Historic Share-based Compensation for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to $50.7 million.

  • Agilon Health's Share-based Compensation fell 4344.97% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.3 million, marking a year-over-year decrease of 1373.23%. This contributed to the annual value of $50.7 million for FY2024, which is 2710.7% down from last year.
  • According to the latest figures from FY2024, Agilon Health's Share-based Compensation is $50.7 million, which was down 2710.7% from $69.5 million recorded in FY2023.
  • Agilon Health's Share-based Compensation's 5-year high stood at $292.4 million during FY2021, with a 5-year trough of $6.7 million in FY2020.
  • Its 5-year average for Share-based Compensation is $89.5 million, with a median of $50.7 million in 2024.
  • As far as peak fluctuations go, Agilon Health's Share-based Compensation soared by 427191.99% in 2021, and later tumbled by 9029.36% in 2022.
  • Agilon Health's Share-based Compensation (Annual) stood at $6.7 million in 2020, then skyrocketed by 4271.92% to $292.4 million in 2021, then crashed by 90.29% to $28.4 million in 2022, then skyrocketed by 144.86% to $69.5 million in 2023, then dropped by 27.11% to $50.7 million in 2024.
  • Its Share-based Compensation was $50.7 million in FY2024, compared to $69.5 million in FY2023 and $28.4 million in FY2022.